Use of proton pump inhibitor and histamine-2 receptor antagonist use and risk of gastric cancer in two population-based studies.

  • Peipei Liu (Advisor)

Activity: Talk or presentation typesOral presentation

Period15 Sept 202117 Sept 2021
Held atInternational Society for Pharmacoepidemiology